Reports are discounted or included with certain Membership Options.

Molecular Diagnostics: Technologies and Global Markets

Jun 2015| BIO063C| BCC Publishing

Customize Report

Report Highlights

The global molecular diagnostics market was valued at almost $21.7 billion in 2014. The total market is projected to grow at a compound annual growth rate (CAGR) of 12.5% from 2015 through 2020 to reach nearly $25.2 billion by 2015 and $45.2 billion by 2020.

Report Includes

An overview of the global market for molecular diagnostics.
Analyses of global market trends, with data from 2012, 2013 and 2014 estimates for 2015, and projections of CAGRs through 2020.
Discussion of related issues, such as government regulation, reimbursement through insurance, patient confidentiality, and other legal ramifications.
Identification of scientific challenges and advances, including the latest trends in the market.
A relevant patent analysis.
Comprehensive company profiles of major players in the field of molecular diagnostics.

Report Scope

This study examines the global market for assays used to detect specific nucleic acid sequences in medical and life sciences applications. While the goal of all DNA-based diagnostic assays is similar, several different technologies can be employed. BCC Research analyzes each technology in detail, determines major players and current market status and presents forecasts of growth over the next five years. Scientific challenges and advances including the latest trends are emphasized. We examine government regulations, major collaborations, recent patents and factors affecting the industry globally. In addition, we examine new directions for DNA diagnostic technologies and emerging applications in clinical diagnostics.

Analyst Credentials

JON EVANS has been involved in business development and research for the biotechnology industry since 1984. He has been involved in sales, market research and strategy analysis with Fortune 500 clients - with a particular focus on business development challenges and strategies to optimize market performance. He holds a B.S. degree in biology from Rutgers University and MBA in business analysis from San Francisco State University.

Latest reports include:

In Vitro Diagnostics: Technologies and Global Markets (HLC186C)

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com

[+] Show Chapter Details

	Title/Chapter Name	Pages	Price	Member Price
	Full Report: Molecular Diagnostics: Technologies and Global Markets	179	$2,750	Free
	Chapter- 1: INTRODUCTION	3		Free
STUDY GOALS AND OBJECTIVES REASONS FOR DOING THE STUDY SCOPE OF REPORT INTENDED AUDIENCE METHODOLOGY AND INFORMATION SOURCES ANALYST'S CREDENTIALS RELATED BCC RESEARCH REPORTS BCC RESEARCH WEBSITE DISCLAIMER
	Chapter- 2: SUMMARY	2	$250	Free
FORECASTS VENDORS
	Chapter- 3: OVERVIEW	5	$77	Free
OVERVIEW INTRODUCTION TO GENOMIC DIAGNOSTICS EXPRESSION PROFILING AND DISEASE EXPRESSION PROFILING AND INFECTIOUS DISEASE DNA SEQUENCING FOR GENOTYPING AND DIAGNOSIS CLINICAL PHARMACOLOGY MUTATION DETECTION AND GENOTYPING FOR SPECIFIC GENES IDENTIFICATION OF NEW DISEASE GENES
	Chapter- 4: REGULATIONS AND FINANCE	34	$522	Free
OVERVIEW INSURANCE FOOD AND DRUG ADMINISTRATION GUIDELINES CLINICAL LABORATORY IMPROVEMENT AMENDMENTS (CLIA) PERSONALIZED MEDICINES AND COMPANION DIAGNOSTICS
	Chapter- 5: COMMERCIAL MARKET TRENDS	5	$77	Free
MARKET CONDITIONS NEW REQUIREMENTS FOR SUCCESS
	Chapter- 6: MARKET FOR MOLECULAR DIAGNOSTICS BY TECHNOLOGY	25	$384	Free
OVERVIEW MICROARRAY PCR IN SITU HYBRIDIZATION (ISH) LAB-ON-A-CHIP/BIOCHIPS EMERGING AND OTHER DIAGNOSTIC TECHNOLOGIES
	Chapter- 7: MARKETS FOR MOLECULAR DIAGNOSTICS BY APPLICATION AND PRODUCTS	22	$338	Free
OVERVIEW PRE-/POSTNATAL GENETIC SCREENING INFECTIOUS DISEASE DIAGNOSTICS ONCOLOGY DIAGNOSTICS IDENTITY DIAGNOSTICS, FORENSICS AND PATERNITY PHARMACOGENOMICS/OTHER APPLICATIONS
	Chapter- 8: PATENT ANALYSIS	29	$446	Free
PCR REAL TIME PCR DETECTION OF RESPIRATORY SYNCYTIAL VIRUS NUCLEIC ACID AMPLIFICATION PRIMERS FOR PCR-BASED CLONALITY STUDIES QUANTITATIVE MULTIPLEX METHYLATION SPECIFIC PCR METHOD- CMETHDNA, REAGENTS, AND ITS USE REAL-TIME PCR DETECTION OF STREPTOCOCCUS PYOGENES REAL-TIME PCR FOR THE DETECTION OF PATHOGENS QUANTITATIVE MULTIPLEX METHYLATION-SPECIFIC PCR REAL-TIME PCR DETECTION OF MYCOBACTERIUM TUBERCULOSIS COMPLEX REAL TIME PCR DETECTION OF M. TUBERCULOSIS RESISTANT/SUSCEPTIBLE TO RIFAMPICIN AND/OR ISONIAZID ABSOLUTE PCR QUANTIFICATION COMPOSITIONS AND METHOD FOR MEASURING AND CALIBRATING AMPLIFICATION BIAS IN MULTIPLEXED PCR REACTIONS REAL-TIME PCR DETECTION OF SEASONAL INFLUENZA H1, H3 AND B SUBTYPES MULTIMODAL PCR TARGET DETECTION COMPOSITION TO OVERCOME INHIBITORS IN PCR AND GROWTH CULTURES MAGNETIC IMMUNO DIGITAL PCR ASSAY CUTOFF POINT DELTA CT. METHOD FOR HER2 PCR TESTING IN BREAST CANCER METHODS AND COMPOSITIONS FOR PCR USING BLOCKED AND UNIVERSAL PRIMERS PCR ASSAYS AND REAGENTS FOR MOLECULAR DETECTION OF INFECTIOUS AGENTS RANDOM HOMOZYGOUS GENE PERTURBATION (RHGP) WITH THERMAL ASSYMETRIC INTERLACED (TAIL)-PCR MICRO RNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF OVARIAN CANCER USING A REAL-TIME PCR PLATFORM PCR METHODS FOR CHARACTERIZING THE 5' UNTRANSLATED REGION OF THE FMR1 AND FMR2 GENES MULTIPLEX PCR-BASED TESTING OF CUTANEOUS SQUAMOUS CELL CARCINOMA AND PSEUDOEPITHELIOMATOUS HYPERPLASIA AND METHODS FOR DISTINGUISHING THE SAME IDENTIFICATION OF ANTIGEN-SPECIFIC ADAPTIVE IMMUNE RESPONSES USING ARM-PCR AND HIGH-THROUGHPUT SEQUENCING QUANTITATIVE MULTIPLEX METHYLATION-SPECIFIC PCR PCR DIAGNOSTICS OF DERMATOPHYTES AND OTHER PATHOGENIC FUNGI HIGHLY MULTIPLEX PCR METHODS AND COMPOSITIONS SINGLE TUBE QUANTITATIVE POLYMERASE CHAIN REACTION (PCR) HIGHLY MULTIPLEX PCR METHODS AND COMPOSITIONS IDENTIFICATION OF LINKAGE USING MULTIPLEX DIGITAL PCR METHODS AND COMPOSITIONS TO ENABLE MULTIPLEX COLD-PCR METHODS OF DIAGNOSING DISEASE USING OVERLAP EXTENSION PCR HOT-START DIGITAL PCR METHOD FOR DETECTION, DIFFERENTIATION AND QUANTIFICATION OF T CELL POPULATIONS BY WAY OF REVERSE TRANSCRIPTION QUANTITATIVE REAL TIME PCR (RT-QPCR) TECHNOLOGY NDM-1 POLYMERASE CHAIN REACTION (PCR) ASSAY DETECTION OF MICRO METASTASIS OF MELANOMA AND BREAST CANCER IN PARAFFIN-EMBEDDED TUMOR DRAINING LYMPH NODES BY MULTIMARKER QUANTITATIVE RT-PCR LATE-PCR HEMOMOSAIC: HIGH-THROUGHPUT TECHNIQUE FOR RARE CELL DETECTION IN LIQUID SAMPLES BY MASSIVELY MULTIPLEXED PCR IN A PHOTOLITHOGRAPHIC MATRIX SERIAL QUANTITATIVE PCR ASSAY FOR DETECTION, SPECIES-DISCRIMINATION AND QUANTIFICATION OF LEISHMANIA SPP. IN HUMAN SAMPLES GENE DETECTING METHODS WITHOUT USING PCR HIGHLY MULTIPLEX PCR METHODS AND COMPOSITIONS PROCESS FOR DETECTION OF MULTIDRUG RESISTANT TUBERCULOSIS USING REAL-TIME PCR AND HIGH RESOLUTION MELT ANALYSIS ISOFORMS OF THE HUMAN SST5 RECEPTOR ORIGINATED BY ALTERNATIVE SPLICING AND OLIGONUCLEOTIDE PAIRS TO DETECT THEM BY PCR REAL TIME PCR ASSAY FOR DETECTION OF BACTERIAL RESPIRATORY PATHOGENS METHODS AND COMPOSITIONS RELATED TO CONTINUOUS FLOW THERMAL GRADIENT PCR METHOD FOR DETECTING MORE THAN ONE TARGET IN A PCR-BASED APPROACH APPLYING AN UN-SPECIFIC DYE WHICH IS NOT INTERFERING WITH THE EMISSION OF FLUOROPHORE-LABELED PROBES MICROARRAY METHODS AND SYSTEMS FOR MANUFACTURE OF MICROARRAY ASSAY SYSTEMS, CONDUCTING MICROFLUIDIC ASSAYS, AND MONITORING AND SCANNING TO OBTAIN MICROFLUIDIC ASSAY RESULTS SYMMETRICALLY BRANCHED POLYMER CONJUGATES AND MICROARRAY ASSAYS TWO-DIMENSIONAL PHOTONIC CRYSTAL MICROARRAY MEASUREMENT METHOD AND APPARATUS FOR HIGHLY-SENSITIVE LABEL-FREE MULTIPLE ANALYTE SENSING, BIOSENSING, AND DIAGNOSTIC ASSAY SOURCE CONTROLLED DECODABLE MICROARRAY SYSTEM AND METHODS FOR USE MICROARRAY BASED SAMPLE DETECTION SYSTEM MICROARRAY FABRICATION SYSTEM AND METHOD MICROARRAY FOR DETECTING VIABLE ORGANISMS SERUM-BASED MIRNA MICROARRAY AND ITS USE IN DIAGNOSIS AND TREATMENT OF BARRETT'S ESOPHAGUS (BE) AND ESOPHAGEAL ADENOCARCINOMA (EAC) LUMINOPHORE-LABELED MOLECULES COUPLED WITH PARTICLES FOR MICROARRAY-BASED ASSAYS Y-SHAPED PROBE AND VARIANT THEREOF, AND DNA MICROARRAY, KIT AND GENETIC ANALYSIS METHOD USING THE SAME MICROARRAY-BASED ASSAY INTEGRATED WITH PARTICLES FOR ANALYZING MOLECULAR INTERACTIONS MICROARRAY FABRICATION SYSTEM AND METHOD ALLERGEN MICROARRAY PHOTONIC CRYSTAL MICROARRAY LAYOUTS FOR ENHANCED SENSITIVITY AND SPECIFICITY OF LABEL-FREE MULTIPLE ANALYTE SENSING, BIOSENSING AND DIAGNOSTIC ASSAY ISH CELL PREPARATIONS AND CELL SUPPORTS AND THEIR USE IN THERANOSIS ULTRA SENSITIVE METHOD FOR IN SITU DETECTION OF NUCLEIC ACIDS BACH2 REPRESSION IN CELLS IN SITU HYBRIDIZATION METHOD AND BUFFER BIOCHIP BIOCHIP AND TARGET DNA QUANTITATIVE METHOD UNITARY BIOCHIP PROVIDING SAMPLE-IN TO RESULTS-OUT PROCESSING AND METHODS OF MANUFACTURE BIOCHIP AND FABRICATION THEREOF UNITARY BIOCHIP PROVIDING SAMPLE-IN TO RESULTS-OUT PROCESSING AND METHODS OF MANUFACTURE BIOCHIP ASSEMBLY AND ASSAY METHOD THEREOF BIOCHIP
	Chapter- 9: COMPANY PROFILES	54	$830	Free
ABBOTT MOLECULAR ADVANDX INC. AFFYMETRIX INC. AGILENT TECHNOLOGIES INC. AUTOGENOMICS INC. BECKMAN COULTER INC. (OWNED BY DANAHER) BECTON DICKINSON AND COMPANY BIOMERIEUX SA BIO-RAD LABORATORIES CALIPER LIFE SCIENCES INC. THE CARLYLE GROUP CEPHEID CURAGEN CORP. (ACQUIRED BY CELLDEX) DECODE GENETICS DNA DIAGNOSTICS CENTER ELITECH GROUP EMD MILLIPORE EUROGENTEC (OWNED BY KANEKA CORP.) EXACT SCIENCES CORP. GE HEALTHCARE HOLOGIC INC. HTG MOLECULAR DIAGNOSTICS ILLUMINA LABORATORY CORP. OF AMERICA (LABCORP) LIFE TECHNOLOGIES LUMINEX CORP MICRONICS INC. MYRIAD GENETICS NOVARTIS MOLECULAR DIAGNOSTICS OXFORD GENE TECHNOLOGY IP LTD. PATHOGENETIX PROMEGA QIAGEN N.V. QUEST DIAGNOSTICS ROCHE SAVYON DIAGNOSTICS SEQUENOM INC. SIEMENS SORENSON GENOMICS INC. THERMO FISHER SCIENTIFIC INC. TRANSGENOMIC INC.

Published - Mar-2013| Analyst - Jon Evans| Code - BIO063B

Report Highlights

In 2012, the global DNA diagnostics market was valued at $17.3 billion. The total market is projected to reach $20.1 billion in 2013 and nearly $36.5 billion by 2018, increasing at a compound annual growth rate (CAGR) of 12.6% from 2013 through 2018.

Report Includes

An overview of the global market for molecular diagnostics.
Analyses of global market trends, with data from 2010 through 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
Discussion of related issues, such as government regulation, reimbursement through insurance, patient confidentiality, and other legal ramifications.
Identification of scientific challenges and advances, including the latest trends.
Comprehensive company profiles and a patent analysis.

Published - Jun-2008| Analyst - Amy Brock| Code - BIO063A

Report Highlights

This Report:

By the end of 2008, the global DNA diagnostics market is expected to be valued at $10.6 billion. The total market is projected to grow at a compound annual growth rate (CAGR) of 13.7% to reach $20.1 billion in 2013.
PCR-based diagnostic assays should claim the largest share of the market in 2008 and be worth $5.4 billion. The segment will reach $9.5 billion in 2013, for a CAGR of 11.9%.
The fastest growing segment of the DNA diagnostics market is the LOAC market, which is expected to reach $890 million in 2008 and $2.1 billion in 2013, for a CAGR of 18.7%.

FAQ

Molecular Diagnostics: Technologies and Global Markets

Single User License: $2750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

Thousands of recently published reports from select publishers
Member Discounts of up to 50% on over 20,000 additional reports from all publishers
Our analysts and research concierge for all inquiries

RELATED REPORTS

Share This Report